Real‐World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome

BACKGROUND: Management of patients with non–ST‐segment–elevation acute coronary syndrome (NSTE‐ACS) is based on 2020 European Society of Cardiology guidelines, which recommend the preferential use of prasugrel over ticagrelor. Because the selection of the respective P(2)Y(12) inhibitor has to consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildirim, Mustafa, Mueller‐Hennessen, Matthias, Milles, Barbara Ruth, Biener, Moritz, Hund, Hauke, Frey, Norbert, Giannitsis, Evangelos, Salbach, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492934/
https://www.ncbi.nlm.nih.gov/pubmed/37581388
http://dx.doi.org/10.1161/JAHA.123.030879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492934/
https://www.ncbi.nlm.nih.gov/pubmed/37581388
http://dx.doi.org/10.1161/JAHA.123.030879

Ejemplares similares